Amarin Corp Plc (AMRN)

[roadkilll]

The generics want Pfizer to go away as soon as possible. Folks would be amazed at what Pfizer could accomplish with the skinny label gone wild.

Remember it was GSK that exposed the skinny label abuse in court, not a small Pharma. Most would probably agree if Amarin could accomplish $600M in sales Pfizer could do 5X those sales without any expansion in sales force (cost Amarin $125M yearly). And the overhead at home office wouldn't exist.

A matter of when not if Pfizer takes over. I'm guessing before China's approval. You actually need Pfizer on the label the consumer sees in ROW. And I also believe in the right hands Vascepa could be in the ballpark of statins.

Noted on recent PR
Lipitor - 45 patients treated 5 years prevented a bad outcome
Vascepa - 21 patients treated 5 years prevented a bad outcome

If Pfizer liked Lipitor and created a blockbuster against multiple generics and other statins what could it do with Vascepa with no competition?